Harare: Zimbabwe has achieved an unprecedented milestone in its tobacco sector, with sales surpassing 300 million kilograms of tobacco leaves since the marketing season began in March 2025-the highest production in the country’s history, according to …
Month: June 2025
Muscat Stock Exchange Index Closes Down by 0.59%
Muscat: The Muscat Stock Exchange (MSX) 30 index closed today at 4,513.93 points, marking a decline of 26.6 points or 0.59% from the previous trading session, which had stood at 4,540.54 points.
According to Yemen News Agency, the trading value on …
European Stocks Edge Higher Following Ceasefire Between Iran & Israel
Muscat: European stocks saw a slight rise on Wednesday as investors viewed the ceasefire between the Israeli occupation and Iran as a sign of easing tensions. The European Stoxx 600 index climbed 0.2% to 542.12 points. Other major European indices als…
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current […]
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current […]
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current […]